IAVI and CureVac partner to accelerate development and testing of AIDS vaccine candidates
Researchers at IAVI's Neutralizing Antibody Center at The Scripps Research Institute and elsewhere have designed several novel immunogens that have the potential to elicit such antibodies.
Oct 16, 2015, 20:39 PM IST